Effect of extremely low-frequency and radiofrequency electromagnetic field exposure on the expression of phosphorylated Tau protein in human neuroblastoma

Document Type : Original Research

Authors

1 PhD student of the department of biophysics, faculty of biological sciences, Tarbiat Modares University, Tehran, Iran

2 Department of Biophysics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran

3 Department of Brain and Cognitive Sciences, Royan institute for stem cell biology and technology, Tehran, Iran

4 Department of Medical Physics and Engineering, School of Medicine, Shiraz University of Medical Sciences

Abstract
Aims

Alzheimer's disease (AD) is a neurodegenerative disease characterized by the progressive loss of neurons leading to cognitive and memory decay. Accumulation of phosphorylated cis-tau inside neurons is considered a factor in AD's pathological features. This study investigated the effects of extremely low-frequency (EMF) and radiofrequency (RF) electromagnetic fields on the proliferation and expression of phosphorylated tau in SH-SY5Y neuroblastoma cells.

Materials and Methods

SH-SY5Y cells treated were exposed to 50 Hz, 20 mT EMF, and 900 MHz for 24, 48, 72, and 96 hours, and the number of the viable cell were determined by MTT assay. Tau protein phosphorylation level was examined after exposure to EMF and RF at different time intervals.

Results

Exposure to the EMF and RF alone had no significant effect on the viability of SH-SY5Y cells compared to sham-exposed cells. However, the expression of phosphorylated cis-tau was significantly increased after exposure.

Conclusion

This study suggests that exposure of human neuroblastoma cells to a 50 Hz electromagnetic field and 900 MHz radiofrequency might induce phosphorylated cis-tau and thus enhance the potency of AD.

Keywords

Subjects


-1 Shiravandi, A, Yari, F, Tofigh, N et al. (2022) Earlier Detection of Alzheimer’s Disease Based on a Novel Biomarker cis P-tau by a Label-Free Electrochemical Immunosensor. Biosensors 12(10):879.
-2 Busche, MA and Hyman, BT. (2020) Synergy between amyloid-β and tau in Alzheimer’s disease. Nature neuroscience 23(10):1183-1193.
-3 Albayram, O, Herbert, MK, Kondo, A et al. (2016) Function and regulation of tau conformations in the development and treatment of traumatic brain injury and neurodegeneration. Cell & Bioscience 6(1):1-6.
-4 Hu, C, Zuo, H and Li, Y. (2021) Effects of radiofrequency electromagnetic radiation on neurotransmitters in the brain. Frontiers in Public Health:1139.
-5 Touitou, Y and Selmaoui, B. (2022) The effects of extremely low-frequency magnetic fields on melatonin and cortisol, two marker rhythms of the circadian system. Dialogues in clinical neuroscience.
-6 Dasdag, O, Adalier, N and Dasdag, S. (2020) Electromagnetic radiation and Alzheimer’s disease. Biotechnology & Biotechnological Equipment 34(1):1087-1094.
-7 Wyszkowska, J and Pritchard, C. (2022) Open Questions on the Electromagnetic Field Contribution to the Risk of Neurodegenerative Diseases. International Journal of Environmental Research and Public Health 19(23):16150.
-8 Jalilian, H, Teshnizi, SH, Röösli, M and Neghab, M. (2018) Occupational exposure to extremely low frequency magnetic fields and risk of Alzheimer disease: a systematic review and meta-analysis. Neurotoxicology 69:242-252.
-9 Jooyana N., GB, Bigdelia B., Faraji-Danab R., ZamanicA., Entezamib M., Mortazavi S.M.J.,. (2019) Direct and indirect effects of exposure to 900 MHz GSM radiofrequency electromagnetic fields on CHO cell line: Evidence of bystander effect by nonionizing radiation. Environmental Research 174:176-187. doi:https://doi.org/10.1016/j.envres.2019.03.063.
-10 Agholme, L, Lindström, T, Kågedal, K, Marcusson, J and Hallbeck, M. (2010) An in vitro model for neuroscience: differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons. Journal of Alzheimer's disease 20(4):1069-1082.
-11 Nisbet, RM and Götz, J. (2018) Amyloid-β and Tau in Alzheimer’s disease: novel pathomechanisms and non-pharmacological treatment strategies. Journal of Alzheimer's Disease 64(s1):S517-S527.
-12 Davanipour, Z and Sobel, E. (2009) Long-term exposure to magnetic fields and the risks of Alzheimer's disease and breast cancer: Further biological research. Pathophysiology 16(2-3):149-156.
-13 D’Angelo, C, Costantini, E, Kamal, M and Reale, M. (2015) Experimental model for ELF-EMF exposure: Concern for human health. Saudi journal of biological sciences 22(1):75-84.
-14 Huss, A, Spoerri, A, Egger, M, Röösli, M and Study, SNC. (2009) Residence near power lines and mortality from neurodegenerative diseases: longitudinal study of the Swiss population. American journal of epidemiology 169(2):167-175.
-15 García, AM, Sisternas, A and Hoyos, SP. (2008) Occupational exposure to extremely low frequency electric and magnetic fields and Alzheimer disease: a meta-analysis. International journal of epidemiology 37(2):329-340.
-16 Dasdag, S, Akdag, MZ, Kizil, G, Kizil, M, Cakir, DU and Yokus, B. (2012) Effect of 900 MHz radio frequency radiation on beta amyloid protein, protein carbonyl, and malondialdehyde in the brain. Electromagnetic biology and medicine 31(1):67-74.
-17 Nakamura, K, Greenwood, A, Binder, L et al. (2012) Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer's disease. Cell 149(1):232-244.